Ark Surgical

Ark Surgical is an FDA-cleared women’s health MedTech company now launching U.S. commercialization of LapBox®, its differentiated tissue containment platform for minimally invasive gynecologic surgery. LapBox® is designed to help surgeons perform laparoscopic and robotic hysterectomy and myomectomy while reducing the risk of tissue dissemination during tissue extraction—supporting safer care in an environment of heightened patient-safety and medico-legal scrutiny. The company’s dual-wall containment technology enables contained workflows for both manual and power tissue morcellation, providing a scalable solution for hospitals seeking to preserve the benefits of minimally invasive surgery while strengthening safety standards. Ark is building adoption through surgeon champions, clinical evidence generation, and targeted health-system entry, with a strategy oriented toward strategic partnerships with leading global women’s health and surgical device players. With clear regulatory status, strong clinical pull, and a large addressable procedure base, Ark is positioned to become a category leader in safe minimally invasive tissue extraction.